Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial

The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics

(2019) John J.V. McMurray et al.   EUROPEAN JOURNAL OF HEART FAILURE

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

(2019) Michael E. Nassif et al.   CIRCULATION

Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas

(2018) Pooja Dewan et al.   EUROPEAN JOURNAL OF HEART FAILURE

Cardiac Resynchronization and Quality of Life in Patients With Minimally Symptomatic Heart Failure

(2012) Peter J. Veazie et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study

(2011) Inger Ekman et al.   EUROPEAN HEART JOURNAL

Effects of Exercise Training on Health Status in Patients With Chronic Heart Failure

(2009) Kathryn E. Flynn et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION